Shanghai Medical College, Fudan University, Shanghai, 200040, China.
Acta Neurochir (Wien). 2012 Aug;154(8):1361-70; discussion 1370. doi: 10.1007/s00701-012-1418-x. Epub 2012 Jun 23.
The marginal delineation of gliomas cannot be defined by conventional imaging due to their infiltrative growth pattern. Here we investigate the relationship between changes in glioma metabolism by proton magnetic resonance spectroscopic imaging ((1)H-MRSI) and histopathological findings in order to determine an optimal threshold value of choline/N-acetyl-aspartate (Cho/NAA) that can be used to define the extent of glioma spread.
Eighteen patients with different grades of glioma were examined using (1)H-MRSI. Needle biopsies were performed under the guidance of neuronavigation prior to craniotomy. Intraoperative magnetic resonance imaging (MRI) was performed to evaluate the accuracy of sampling. Haematoxylin and eosin, and immunohistochemical staining with IDH1, MIB-1, p53, CD34 and glial fibrillary acidic protein (GFAP) antibodies were performed on all samples. Logistic regression analysis was used to determine the relationship between Cho/NAA and MIB-1, p53, CD34, and the degree of tumour infiltration. The clinical threshold ratio distinguishing tumour tissue in high-grade (grades III and IV) glioma (HGG) and low-grade (grade II) glioma (LGG) was calculated.
In HGG, higher Cho/NAA ratios were associated with a greater probability of higher MIB-1 counts, stronger CD34 expression, and tumour infiltration. Ratio threshold values of 0.5, 1.0, 1.5 and 2.0 appeared to predict the specimens containing the tumour with respective probabilities of 0.38, 0.60, 0.79, 0.90 in HGG and 0.16, 0.39, 0.67, 0.87 in LGG.
HGG and LGG exhibit different spectroscopic patterns. Using (1)H-MRSI to guide the extent of resection has the potential to improve the clinical outcome of glioma surgery.
由于胶质瘤呈浸润性生长,常规影像学无法明确其边界。本研究旨在通过质子磁共振波谱成像(1H-MRSI)研究胶质瘤代谢变化与组织病理学改变的关系,以确定可用于定义胶质瘤扩散范围的最佳胆碱/N-乙酰天门冬氨酸(Cho/NAA)比值阈值。
对 18 例不同级别胶质瘤患者行 1H-MRSI 检查,在开颅前于神经导航引导下行针吸活检,术中磁共振成像(MRI)评估取样准确性。对所有标本行苏木精-伊红(HE)染色及 IDH1、MIB-1、p53、CD34 和胶质纤维酸性蛋白(GFAP)免疫组化染色。采用 Logistic 回归分析 Cho/NAA 与 MIB-1、p53、CD34 和肿瘤浸润程度的关系,计算鉴别高级别(III 级和 IV 级)和低级别(II 级)胶质瘤(HGG 和 LGG)肿瘤组织的最佳 Cho/NAA 比值临床阈值。
在 HGG 中,较高的 Cho/NAA 比值与更高的 MIB-1 计数、更强的 CD34 表达和肿瘤浸润概率更高相关。Cho/NAA 比值阈值为 0.5、1.0、1.5 和 2.0 时,预测 HGG 肿瘤组织的概率分别为 0.38、0.60、0.79、0.90,预测 LGG 肿瘤组织的概率分别为 0.16、0.39、0.67、0.87。
HGG 和 LGG 表现出不同的波谱特征。利用 1H-MRSI 指导切除范围可能会改善胶质瘤手术的临床结局。